Jianfeng Ye

机构：Guangzhou University of Chinese Medicine, Guangdong Medical College, Jianghan University, Wuhan University, Dongguan People’s Hospital, Hubei Zhongshan Hospital · ORCID：0000-0002-4203-8555

发表论文 113 篇 · 总被引 2035 次 · h-index 25

代表论文

• Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer (2023 · Cancer Cell · 被引 53)
• Prognosis of critically ill patients with early and late sepsis-associated acute kidney injury: an observational study based on the MIMIC-IV (2025 · Renal Failure · 被引 14)
• TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling (2023 · Cell Death Discovery · 被引 12)
• Efficacy and compatibility mechanism of bear bile powder in Shexiang Tongxin dropping pills for acute myocardial infarction treatment (2025 · Chinese Medicine · 被引 9)
• Lactylation associated biomarkers and immune infiltration in aortic dissection (2025 · Scientific Reports · 被引 5)
• Protective effects of Shexiang-Tongxin dropping pill against acute myocardial infarction in rats through inhibition of apoptosis and ERK/MAPK signaling pathways (2024 · Heliyon · 被引 5)